EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Clinuvel Pharmaceuticals Limited Stock Dividends Overview

CUV.AX pays dividends yearly. Last paid amount was $0.0500 at Sep 20, 2023. As of today, dividend yield (TTM) is 0.324%.

Dividend Yield Range

The Dividend Yield Range is the range of values in which a stock’s dividend yield has fluctuated within a specified period, often a year. It represents the variation between the highest and lowest dividend yields observed during that time frame.
AI Analysis of CUV.AX
Powered by GPT-4o
New!
Dividend Analysis

Key Stats

Dividend Yield (TTM) 0.324%
Frequency Yearly
1Y Growth 0%
Payout Ratio 0
Amount Per Share $0.0500
Clinuvel Pharmaceuticals Limited has not yet announced its next dividend date. Last payment date was: Sep 20, 2023.

CUV Dividend Payout History

To ensure a understanding of CUV's dividend performance, consider examining the historical payout ratios and how they align with the company's earnings. Fluctuations in payout amounts may reflect changes in the company's dividend policy or earnings stability.


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 05, 2023 Sep 05, 2023 Sep 20, 2023 $0.0500 0.324%
2 Sep 06, 2022 Sep 06, 2022 Sep 06, 2022 $0.0400 0.204%
3 Sep 02, 2021 Sep 02, 2021 Sep 02, 2021 $0.0250 0.0657%
4 Aug 27, 2020 Sep 03, 2020 Sep 18, 2020 $0.0250 0.109%
5 Aug 28, 2019 Sep 04, 2019 Sep 19, 2019 $0.0250 0.0990%
6 Aug 29, 2018 Sep 21, 2018 Oct 08, 2018 $0.0200 0.0923%

Dividend Sustainability

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Sustainability score

average (78.89%)

Growth potential

Decrease likely (45.26%)

CUV Dividend Calculator

Dividend Calculator is designed to forecast the potential returns from CUV dividends based on your individual investment size or the number of shares you own. Simply enter your total investment amount to see the cumulative dividend payment you could receive over a specified period.
Read how to invest in CUV stock here.

Comparing CUV to Sector and Country

CUV.AX pays a solid dividend yield of 0.324%, which is lower than the average of the bottom 25% of dividend payers in the AU market (0.90%). CUV.AX’s dividend yield is lower than the average of the top 25% of dividend payers in the Healthcare sector in the AU market (5.53%), which means that there are more attractive dividend stocks to consider.

FAQ

What factors can affect the amount of CUV.AX's dividend payments?
The amount of CUV.AX's dividends can fluctuate based on several factors, including the company's financial performance, earnings, cash flow, capital requirements, and overall market conditions. Changes in CUV.AX sector's trends, interest rate shifts, and the company's operational adjustments can also influence dividend decisions.

Can dividends from CUV.AX stock be automatically reinvested?
If CUV.AX offers a Dividend Reinvestment Plan (DRIP), shareholders may have the option to automatically reinvest dividends to purchase additional shares. Please check with your brokerage for the availability and details of such a plan. Here's an easy guide on how to buy CUV.AX stock.

How often does CUV.AX pay dividend?
Clinuvel Pharmaceuticals Limited (CUV.AX) pays dividends yearly. The most recent payout was on Sep 20, 2023.

How much does CUV.AX pays per share?
The last recorder (Sep 05, 2023) dividend per share was $0.0500.

What is CUV.AX dividend growth rate?
Over the last year, Clinuvel Pharmaceuticals Limited has witnessed growth rate of 0% . Looking back over the past 3 years, this growth rate has been 25.99%. Furthermore, examining the past 5 years, Clinuvel Pharmaceuticals Limited has maintained an average Dividends Per Share Growth Rate of 14.87%.
Click to get the best stock tips daily for free!

About Clinuvel Pharmaceuticals Limited

Clinuvel Pharmaceuticals Limited Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline pr... CUV.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT